CliffBio
small molecule

BUPIVACAINE HYDROCHLORIDE

BUPIVACAINE HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyBaxter Healthcare Corp →See this company's full patent-cliff portfolio

Drug detail

Brand nameBUPIVACAINE HYDROCHLORIDE
Active ingredientBUPIVACAINE HYDROCHLORIDE
Strength0.75%
Dosage formINJECTABLE
RouteSPINAL
ModalitySmall molecule
FDA approvalJuly 2016
Marketing statusDISCN

More from Baxter Healthcare Corp

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.